2022 Agenda

This year’s agenda features industry leaders discussing ground-breaking innovations and our annual LaunchPad Presentations as well as experts speaking on recovering their practice following the healthcare crisis.

Access the OTF 2022 Video Content – View recorded sessions, the keynote, presentations and more. Buy Now.
Thursday, June 16, 2022

3:30 – 5:00 pm PST

EXPERIENCE

Partnership Pursuit: Physician & Entrepreneur Reception – by Invite Only

This is a unique opportunity for you to meet these innovative entrepreneurs and determine if there is a mutually beneficial fit and interest. These companies will be within the medical industry, not necessarily ophthalmic specific, and provide a good opportunity to contribute your diverse perspective. Octane is uniquely qualified to provide this opportunity as we bridge the relationships we have with physicians and the companies that have used our LaunchPad accelerator. We look forward to welcoming you to Balboa Bay Resort in Newport Beach.

5:00 – 7:00 pm PST

EXPERIENCE

Welcome Cocktail Reception (Sponsors, Speakers, and Physicians Only)

Take this time to get to know fellow attendees and make connections!

Friday, June 17, 2022

7:00 – 8:00 am PST

EXPERIENCE

Registration, Exhibits & Continental Breakfast

Network with colleagues! You can also set appointments within our virtual platform or take part in a networking session catered to your interests.

8:00 – 8:05 am PST

OPENING

Opening Comments

Bill Carpou, CEO of Octane will reflect on the impact of ophthalmology in Southern California and beyond.

Bill Carpou, CEO, Octane

8:05 – 8:35 am PST

FEATURED INTERVIEW

Keynote Interview

James V. (Jim) Mazzo, Executive Chairman, Neurotech, Chief Executive Officer, Avellino Labs, Advisor, Zeiss, Advisor, Bain Consulting, Board Member, Centricity Vision Inc. (Moderator)

David Endicott, CEO, Alcon

8:35 – 8:50 am PST

PANEL

State of the Ophthalmic/Financial Industry Report

A market overview of the ophthalmic industry.

Tim Lugo, Head of Biotechnology and Pharmaceutical Equity Research at William Blair

8:50 – 9:30 am PST

PANEL

High Tech – Surgical Suite Integration, AI, Remote Training, Patient Communication Software, TeleHealth

This panel will focus on the future surgical suite. The panel will feature presentations and discussion around integration technology of today and tomorrow, the future of in-office surgery and same-day bilateral surgery, remote training/learning, and telehealth opportunities.

Daniel Durrie, MD, Founder, Durrie Vision, Co-founder, iOR Partners (Moderator)

Tera Roy Ackerman, Sr. Vice President, Nextech Systems

Ranya Habash, MD, CEO, LifeLong Vision; FDA Digital Health Network of Experts, Medical Director, Technology Innovation, Bascom Palmer Eye Institute

Nikki Sidi, Vice President, Global Strategic Marketing, Surgical Vision, Johnson & Johnson Vision

Euan Thomson, PhD, Global President Ophthalmic Devices, Head of Digital Business Unit, Carl Zeiss Meditec

9:30 – 10:00 am PST

EXPERIENCE

Break: Exhibits, and Coffee

Take this time to visit sponsor booths, get to know fellow attendees, and make connections!

10:00 – 10:40 am PST

PANEL

Innovation in Cataract & Refractive

This session will feature 5 top Innovative surgical technologies along with a panel discussion on what Is hot in the world of cataract and refractive surgery.

John Hovanesian, MD, FACS, Private Practice, Harvard Eye Associates, Laguna Hills, CA Clinical Faculty, UCLA Jules Stein Eye Institute, Los Angeles, CA (Moderator)

Arturo Chayet, MD, Codet Vision Institute

Cristos Ifantides, MD, MBA Director, Ophthalmic Global Outreach at University of Colorado Anschutz Medical Campus

Cynthia Matossian, MD, FACS, Founder, Matossian Eye Associates, President, CM Associates LLC

Lisa Nijm, MD, JD, Warrenville Eye Care & LASIK Center

Farrell “Toby” Tyson, MD, FACS,  Tyson Eye, Visionary Venture Fund Co-Founder

10:40- 11:20 am PST

PANEL

Current State and Future Outlook of the Ophthalmic Landscape

*This will be an interactive panel

What are some of the challenges and strategies, compliance, industry perspectives? Pathways to the FDA, challenges, funding, prioritizing board diversity? Supply chain issues, lingering effects of COVID, getting enough patients in trials.

Marty Waters, Partner, Wilson Sonsini (Moderator)

Jag Dosanjh, President, U.S. Neuroscience and Eyecare, AbbVie

Bill Link, PhD, Managing Partner, Flying L Partners

Richard Lindstrom, MD, Minnesota Eye Consultants

Caren Mason, President & CEO, STAAR Surgical

11:20 am – 11:30 pm PST

EXPERIENCE

The Roger Steinert, MD Legacy Award Presented by The Gavin Herbert Eye Institute

11:30 – 12:00 pm PST

EXPERIENCE

Break: Exhibits & Set for Lunch

12:00 – 12:40 pm PST

LUNCH PANEL

Lunch: Innovation Leadership Panel – Device

Industry executive panel discussions focused on innovation in the device industry.

Elizabeth Yeu, MD, Partner, Virginia Eye Consultants (Moderator)

Laurent Attias, Senior Vice President, Corporate Development Strategy, BD&L and M&A, Alcon

Chuck Hess, Vice President US Surgical Marketing, Bausch & Lomb

MK Raheja, PhD, Head, Surgical Vision R&D, Johnson & Johnson Vision

12:40 – 1:20 pm PST

LUNCH PANEL

Lunch: Innovation Leadership Panel – Pharma

Industry executive panel discussion focused on innovation in the pharma space.

Aziz Mottiwala, Chief Commercial Officer, Tarsus Pharmaceuticals, Inc. (Moderator)

David Acheson, Senior Vice President, North America, Apellis Pharmaceuticals

Mark Hagler, Senior Vice President, Head Ophthalmics, Oncology & Radiopharma, Sun Pharmaceutical Industries, Inc.

Darius Kharabi, JD, MBA, Chief Business Officer, Kala Pharmaceuticals

Greg Kunst, President & CEO, Aurion Biotech

Michelle Senchyna, PhD, Vice President, Clinical Development and Medical Affairs, Aerie Pharmaceuticals

1:20 – 1:50 pm PST

EXPERIENCE

Break: Exhibits & Coffee

 

1:50 – 2:30 pm PST

PANEL & PRESENTATIONS

Advances in Retina

This session will feature 3 top innovative retinal companies as well as an overview and discussion on what is hot in Retina’s world.

Robert L. Avery, MD, California Retina Consultants (Moderator)

Kerrie Brady, President and Chief Executive Officer, OcuTerra Therapeutics

Baruch Kuppermann, MD, PhD, Roger F. Steinert Professor and Chair, Department of Ophthalmology, School of Medicine, Director, Gavin Herbert Eye Institute School of Medicine

Mark Humayun, MD, PhD, University Professor of Ophthalmology, Director, Institute for Biomedical Therapeutics,Co-Director USC Roski Eye Institute,Director of Sensory Science Initiatives, Cornelius J. Pings Chair in Biomedical Sciences, Keck School of Medicine, USC

Michael J. O’Rourke, CEO, Re-Vana Therapeutics

Richard Small, CEO, Neurotech Pharmaceuticals, Inc.

2:30 – 3:10 pm PST

PANEL

Physician / Entrepreneur Insights – Pitfalls and Transcendent Moments

Activating physician entrepreneurs. What is the physician journey to entrepreneurism?

Ehsan Sadri, MD, FACS, Founding Member, Visionary Venture Fund (Moderator) 

Jeffry Weinhuff, Managing Partner, Visionary Venture Fund (Moderator)

Bobak Azamian, MD, PhD, CEO, Tarsus Pharmaceuticals

Kamran Hosseini, MD, PhD, Surface Ophthalmics Inc.

Sean Ianchulev, MD, MPH, Chief Executive Officer, Chief Medical Officer, Director, Founder, Eyenovia

Richard Lindstrom, MD, Minnesota Eye Consultants

3:10 – 3:50 pm PST

PANEL

New Innovations in Presbyopia & Myopia

Yari Mitchell, Chief Business Development Officer, AcuFocus Inc. (Moderator)

Scott Barnes, MD, Chief Medical Officer, STAAR Surgical

Patrick Johnson, Chief Business Officer, Sydnexis

Elad Kadar, CEO, Orasis Pharmaceuticals

Marc Odrich, MD, Chief Medical Officer, LENZ Therapeutics

Michael Rowe, Chief Operating Officer, Eyenovia Inc.

Julia Williams, Vice President of Clinical and Medical Affairs, Visus Therapeutics

3:50 – 5:30 pm PST

LAUNCHPAD

LaunchPad SBDC Company Presentations & Award

A highlight of each year’s Ophthalmology Tech Summit are the presentations by companies who have recently been through the LaunchPad SBDC evaluation process. The LaunchPad presentations are the result of select ophthalmology companies who have recently been through the LaunchPad evaluation process. It is one of the most highly anticipated sessions of Octane’s annual Ophthalmology Tech Summit.

LaunchPad Companies:

ForwardVue Pharma, Inc.

IOPtic, Inc.

Kato Pharmaceuticals

Capital & Growth Companies:

SalutarisMD

Smartlens

Andrew Douglas, Partner, Knobbe Martens (Moderator)
Mike Hill, Director, LaunchPad SBDC, Octane

Investor Judges:

Tara Capalbo, General Manager, Glaucoma, Allergan, an AbbVie Company

Sanjeev Ganatra, SVP, Sales & Marketing, CBCC Global Research

Sheri Rowen, MD,FACS, NVision Eye Centers

Farrell “Toby” Tyson, MD, Tyson Eye

Learn more.

5:30 – 5:35 pm PST

CLOSING

Closing Comments

5:35 – 7:30 pm PST

EXPERIENCE

Reception
Saturday, June 18, 2022

8:00 am – 1:00 pm PST

EXPERIENCE

Advisory Board Opportunities (By Invitation Only)